ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cyclophosphamide Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: June 2025
|
Report Code: QYRE-Auto-9E9168
Home | Market Reports | Health| Health Conditions| Cancer
Global Cyclophosphamide Market Outlook 2022
BUY CHAPTERS

Global Cyclophosphamide Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-9E9168
Report
June 2025
Pages:134
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Baxter
Novartis
Hikma Pharmaceuticals
Amneal Pharmaceuticals LLC
Jiangsu Hengrui Medicine
NorthStar Rx LLC
GLS Pharma
CSC PHARMACEUTICALS INTERNATIONAL

Cyclophosphamide Market Size

In 2024, the global market size of Cyclophosphamide was estimated to be worth US$ 671 million and is forecast to reach approximately US$ 774 million by 2031 with a CAGR of 2.1% during the forecast period 2025-2031.

Cyclophosphamide Market

Cyclophosphamide Market

Cyclophosphamide (CP), also known as cytophosphane among other names, is a medication used as chemotherapy and to suppress the immune system. As chemotherapy it is used to treat lymphoma, multiple myeloma, leukemia, ovarian cancer, breast cancer, small cell lung cancer, neuroblastoma, and sarcoma.
Top 8 manufacturers took 75.4% market share in 2019.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Cyclophosphamide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cyclophosphamide.
The Cyclophosphamide market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cyclophosphamide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cyclophosphamide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.

Scope of Cyclophosphamide Market Report

Report Metric Details
Report Name Cyclophosphamide Market
Forecasted market size in 2031 approximately US$ 774 million
CAGR 2.1%
Forecasted years 2025 - 2031
Segment by Type
  • High-Dose
  • Low-Dose
Segment by Application
  • Cancer
  • Autoimmune Diseases
  • AL Amyloidosis
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Baxter, Novartis, Hikma Pharmaceuticals, Amneal Pharmaceuticals LLC, Jiangsu Hengrui Medicine, NorthStar Rx LLC, GLS Pharma, CSC Pharmaceuticals International
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Cyclophosphamide in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
  • Chapter 3: Detailed analysis of Cyclophosphamide manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cyclophosphamide sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion.

FAQ for this report

What is the Cyclophosphamide Market size in 2031?

Ans: The Cyclophosphamide Market size in 2031 will be approximately US$ 774 million.

What is the market share of major companies in Cyclophosphamide Market?

Ans: Top 8 manufacturers took 75.4% market share in 2019.

Who are the main players in the Cyclophosphamide Market report?

Ans: The main players in the Cyclophosphamide Market are Baxter, Novartis, Hikma Pharmaceuticals, Amneal Pharmaceuticals LLC, Jiangsu Hengrui Medicine, NorthStar Rx LLC, GLS Pharma, CSC Pharmaceuticals International

What are the Application segmentation covered in the Cyclophosphamide Market report?

Ans: The Applications covered in the Cyclophosphamide Market report are Cancer, Autoimmune Diseases, AL Amyloidosis, Others

What are the Type segmentation covered in the Cyclophosphamide Market report?

Ans: The Types covered in the Cyclophosphamide Market report are High-Dose, Low-Dose

1 Study Coverage
1.1 Cyclophosphamide Product Introduction
1.2 Market by Type
1.2.1 Global Cyclophosphamide Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 High-Dose
1.2.3 Low-Dose
1.3 Market by Application
1.3.1 Global Cyclophosphamide Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Cancer
1.3.3 Autoimmune Diseases
1.3.4 AL Amyloidosis
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Cyclophosphamide Market Size Estimates and Forecasts
2.1.1 Global Cyclophosphamide Revenue 2020-2031
2.1.2 Global Cyclophosphamide Sales 2020-2031
2.2 Cyclophosphamide Market Size by Region: 2024 Versus 2031
2.3 Cyclophosphamide Sales by Region (2020-2031)
2.3.1 Global Cyclophosphamide Sales by Region: 2020-2025
2.3.2 Global Cyclophosphamide Sales Forecast by Region (2026-2031)
2.3.3 Global Cyclophosphamide Sales Market Share by Region (2020-2031)
2.4 Cyclophosphamide Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Cyclophosphamide Revenue by Region: 2020-2025
2.4.2 Global Cyclophosphamide Revenue Forecast by Region (2026-2031)
2.4.3 Global Cyclophosphamide Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Cyclophosphamide Sales by Type (2020-2031)
3.1.1.1 Global Cyclophosphamide Sales Volume by Type (2020-2031)
3.1.1.2 Global Cyclophosphamide Sales Market Share by Type (2020-2031)
3.1.2 Global Cyclophosphamide Revenue by Type (2020-2031)
3.1.2.1 Global Cyclophosphamide Revenue by Type (2020-2031)
3.1.2.2 Global Cyclophosphamide Revenue Market Share by Type (2020-2031)
3.1.3 Cyclophosphamide Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Cyclophosphamide Sales by Application (2020-2031)
3.2.1.1 Global Cyclophosphamide Sales Volume by Application (2020-2031)
3.2.1.2 Global Cyclophosphamide Sales Market Share by Application (2020-2031)
3.2.2 Global Cyclophosphamide Revenue by Application (2020-2031)
3.2.2.1 Global Cyclophosphamide Revenue by Application (2020-2031)
3.2.2.2 Global Cyclophosphamide Revenue Market Share by Application (2020-2031)
3.2.3 Cyclophosphamide Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 High-Dose of Cyclophosphamide Revenue Market Share by Application
3.3.2 Low-Dose of Cyclophosphamide Revenue Market Share by Application
4 Global Cyclophosphamide by Manufacturers
4.1 Global Top Cyclophosphamide Manufacturers by Sales (2020-2025)
4.1.1 Global Cyclophosphamide Sales by Manufacturer (2020-2025)
4.1.2 Global Cyclophosphamide Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Cyclophosphamide Manufacturers by Revenue (2020-2025)
4.2.1 Global Cyclophosphamide Revenue by Manufacturer (2020-2025)
4.2.2 Global Cyclophosphamide Revenue Share by Manufacturer (2020-2025)
4.3 Global Cyclophosphamide Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Cyclophosphamide Manufacturers Covered: Ranking by Revenue
4.4.2 Global Cyclophosphamide Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Cyclophosphamide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Cyclophosphamide Manufacturing Base Distribution, Product Type
4.5.1 Cyclophosphamide Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Cyclophosphamide Market
4.5.3 Manufacturers Cyclophosphamide Product Type and Application
4.5.4 High-Dose Market Sales of Cyclophosphamide by Manufacturer
4.5.5 Low-Dose Market Sales of Cyclophosphamide by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Baxter
5.1.1 Baxter Company Information
5.1.2 Baxter Description, Business Overview
5.1.3 Baxter Cyclophosphamide Products Offered
5.1.4 Baxter Cyclophosphamide Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Baxter Cyclophosphamide Sales by Product in 2024
5.1.6 Baxter Cyclophosphamide Sales by Application in 2024
5.1.7 Baxter Cyclophosphamide Sales by Geographic Area in 2024
5.1.8 Baxter Recent Developments
5.2 Novartis
5.2.1 Novartis Company Information
5.2.2 Novartis Description, Business Overview
5.2.3 Novartis Cyclophosphamide Products Offered
5.2.4 Novartis Cyclophosphamide Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Novartis Cyclophosphamide Sales by Product in 2024
5.2.6 Novartis Cyclophosphamide Sales by Application in 2024
5.2.7 Novartis Cyclophosphamide Sales by Geographic Area in 2024
5.2.8 Novartis Recent Developments
5.3 Hikma Pharmaceuticals
5.3.1 Hikma Pharmaceuticals Company Information
5.3.2 Hikma Pharmaceuticals Description, Business Overview
5.3.3 Hikma Pharmaceuticals Cyclophosphamide Products Offered
5.3.4 Hikma Pharmaceuticals Cyclophosphamide Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Hikma Pharmaceuticals Cyclophosphamide Sales by Product in 2024
5.3.6 Hikma Pharmaceuticals Cyclophosphamide Sales by Application in 2024
5.3.7 Hikma Pharmaceuticals Cyclophosphamide Sales by Geographic Area in 2024
5.3.8 Hikma Pharmaceuticals Recent Developments
5.4 Amneal Pharmaceuticals LLC
5.4.1 Amneal Pharmaceuticals LLC Company Information
5.4.2 Amneal Pharmaceuticals LLC Description, Business Overview
5.4.3 Amneal Pharmaceuticals LLC Cyclophosphamide Products Offered
5.4.4 Amneal Pharmaceuticals LLC Cyclophosphamide Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Amneal Pharmaceuticals LLC Cyclophosphamide Sales by Product in 2024
5.4.6 Amneal Pharmaceuticals LLC Cyclophosphamide Sales by Application in 2024
5.4.7 Amneal Pharmaceuticals LLC Cyclophosphamide Sales by Geographic Area in 2024
5.4.8 Amneal Pharmaceuticals LLC Recent Developments
5.5 Jiangsu Hengrui Medicine
5.5.1 Jiangsu Hengrui Medicine Company Information
5.5.2 Jiangsu Hengrui Medicine Description, Business Overview
5.5.3 Jiangsu Hengrui Medicine Cyclophosphamide Products Offered
5.5.4 Jiangsu Hengrui Medicine Cyclophosphamide Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Jiangsu Hengrui Medicine Cyclophosphamide Sales by Product in 2024
5.5.6 Jiangsu Hengrui Medicine Cyclophosphamide Sales by Application in 2024
5.5.7 Jiangsu Hengrui Medicine Cyclophosphamide Sales by Geographic Area in 2024
5.5.8 Jiangsu Hengrui Medicine Recent Developments
5.6 NorthStar Rx LLC
5.6.1 NorthStar Rx LLC Company Information
5.6.2 NorthStar Rx LLC Description, Business Overview
5.6.3 NorthStar Rx LLC Cyclophosphamide Products Offered
5.6.4 NorthStar Rx LLC Cyclophosphamide Sales, Revenue and Gross Margin (2020-2025)
5.6.5 NorthStar Rx LLC Cyclophosphamide Sales by Product in 2024
5.6.6 NorthStar Rx LLC Cyclophosphamide Sales by Application in 2024
5.6.7 NorthStar Rx LLC Cyclophosphamide Sales by Geographic Area in 2024
5.6.8 NorthStar Rx LLC Recent Developments
5.7 GLS Pharma
5.7.1 GLS Pharma Company Information
5.7.2 GLS Pharma Description, Business Overview
5.7.3 GLS Pharma Cyclophosphamide Products Offered
5.7.4 GLS Pharma Cyclophosphamide Sales, Revenue and Gross Margin (2020-2025)
5.7.5 GLS Pharma Cyclophosphamide Sales by Product in 2024
5.7.6 GLS Pharma Cyclophosphamide Sales by Application in 2024
5.7.7 GLS Pharma Cyclophosphamide Sales by Geographic Area in 2024
5.7.8 GLS Pharma Recent Developments
5.8 CSC Pharmaceuticals International
5.8.1 CSC Pharmaceuticals International Company Information
5.8.2 CSC Pharmaceuticals International Description, Business Overview
5.8.3 CSC Pharmaceuticals International Cyclophosphamide Products Offered
5.8.4 CSC Pharmaceuticals International Cyclophosphamide Sales, Revenue and Gross Margin (2020-2025)
5.8.5 CSC Pharmaceuticals International Cyclophosphamide Sales by Product in 2024
5.8.6 CSC Pharmaceuticals International Cyclophosphamide Sales by Application in 2024
5.8.7 CSC Pharmaceuticals International Cyclophosphamide Sales by Geographic Area in 2024
5.8.8 CSC Pharmaceuticals International Recent Developments
6 North America
6.1 North America Cyclophosphamide Market Size YoY Growth 2020-2031
6.2 North America Cyclophosphamide Market Facts & Figures by Country
6.2.1 North America Cyclophosphamide Sales by Country (2020-2031)
6.2.2 North America Cyclophosphamide Revenue by Country (2020-2031)
6.3 North America Cyclophosphamide Sales by Type (2020-2025)
6.4 North America Cyclophosphamide Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Cyclophosphamide Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Cyclophosphamide Market Facts & Figures by Region
7.2.1 Asia-Pacific Cyclophosphamide Sales by Region (2020-2031)
7.2.2 Asia-Pacific Cyclophosphamide Revenue by Region (2020-2031)
7.3 Asia-Pacific Cyclophosphamide Sales by Type (2020-2025)
7.4 Asia-Pacific Cyclophosphamide Sales by Application (2020-2025)
8 Europe
8.1 Europe Cyclophosphamide Market Size YoY Growth 2020-2031
8.2 Europe Cyclophosphamide Market Facts & Figures by Country
8.2.1 Europe Cyclophosphamide Sales by Country (2020-2031)
8.2.2 Europe Cyclophosphamide Revenue by Country (2020-2031)
8.3 Europe Cyclophosphamide Sales by Type (2020-2025)
8.4 Europe Cyclophosphamide Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Cyclophosphamide Market Size YoY Growth 2020-2031
9.2 Latin America Cyclophosphamide Market Facts & Figures by Country
9.2.1 Latin America Cyclophosphamide Sales by Country (2020-2031)
9.2.2 Latin America Cyclophosphamide Revenue by Country (2020-2031)
9.3 Latin America Cyclophosphamide Sales by Type (2020-2025)
9.4 Latin America Cyclophosphamide Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Cyclophosphamide Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Cyclophosphamide Market Facts & Figures by Country
10.2.1 Middle East and Africa Cyclophosphamide Sales by Country (2020-2031)
10.2.2 Middle East and Africa Cyclophosphamide Revenue by Country (2020-2031)
10.3 Middle East and Africa Cyclophosphamide Sales by Type (2020-2025)
10.4 Middle East and Africa Cyclophosphamide Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Cyclophosphamide Supply Chain Analysis
11.2 Cyclophosphamide Key Raw Materials and Upstream Suppliers
11.3 Cyclophosphamide Clients Analysis
11.4 Cyclophosphamide Sales Channel and Sales Model Analysis
11.4.1 Cyclophosphamide Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Cyclophosphamide Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Cyclophosphamide Distributors
12 Cyclophosphamide Market Dynamics
12.1 Cyclophosphamide Industry Trends
12.2 Cyclophosphamide Market Drivers
12.3 Cyclophosphamide Market Challenges
12.4 Cyclophosphamide Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
FEATURED COMPANIES
Baxter
Novartis
Hikma Pharmaceuticals
Amneal Pharmaceuticals LLC
Jiangsu Hengrui Medicine
NorthStar Rx LLC
GLS Pharma
CSC PHARMACEUTICALS INTERNATIONAL
List of Tables
 Table 1. Global Cyclophosphamide Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global Cyclophosphamide Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global Cyclophosphamide Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global Cyclophosphamide Sales by Region (2020-2025) & (Units)
 Table 5. Global Cyclophosphamide Sales Forecast by Region (2026-2031) & (Units)
 Table 6. Global Cyclophosphamide Revenue by Region (2020-2025) & (US$ Million)
 Table 7. Global Cyclophosphamide Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 8. Global Cyclophosphamide Sales Volume by Type (2020-2025) & (Units)
 Table 9. Global Cyclophosphamide Sales Volume by Type (2026-2031) & (Units)
 Table 10. Global Cyclophosphamide Revenue by Type (2020-2025) & (US$ Million)
 Table 11. Global Cyclophosphamide Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 12. Global Cyclophosphamide Sales Volume by Application (2020-2025) & (Units)
 Table 13. Global Cyclophosphamide Sales Volume by Application (2026-2031) & (Units)
 Table 14. Global Cyclophosphamide Revenue by Application (2020-2025) & (US$ Million)
 Table 15. Global Cyclophosphamide Revenue by Application (2026-2031) & (US$ Million)
 Table 16. Global Cyclophosphamide Sales by Manufacturer (2020-2025) & (Units)
 Table 17. Global Cyclophosphamide Sales Share by Manufacturer (2020-2025)
 Table 18. Cyclophosphamide Revenue by Manufacturer (2020-2025) & (US$ Million)
 Table 19. Cyclophosphamide Revenue Share by Manufacturer (2020-2025)
 Table 20. Key Manufacturers Cyclophosphamide Price (2020-2025) & (US$/Unit)
 Table 21. Ranking of Global Top Cyclophosphamide Manufacturers by Revenue (US$ Million) in 2024
 Table 22. Global Cyclophosphamide Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 23. Global Cyclophosphamide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cyclophosphamide as of 2024)
 Table 24. Cyclophosphamide Manufacturers Manufacturing Base Distribution and Headquarters
 Table 25. Date of International Manufacturers Enter into Cyclophosphamide Market
 Table 26. Manufacturers Cyclophosphamide Product Type and Application
 Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 28. Baxter Company Information
 Table 29. Baxter Description and Business Overview
 Table 30. Baxter Cyclophosphamide Product
 Table 31. Baxter Cyclophosphamide Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 32. Baxter Sales Proportion of Cyclophosphamide by Product in 2024
 Table 33. Baxter Sales Proportion of Cyclophosphamide by Application in 2024
 Table 34. Baxter Sales Proportion of Cyclophosphamide by Geographic Area in 2024
 Table 35. Baxter Recent Developments
 Table 36. Novartis Company Information
 Table 37. Novartis Description and Business Overview
 Table 38. Novartis Cyclophosphamide Product
 Table 39. Novartis Cyclophosphamide Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 40. Novartis Sales Proportion of Cyclophosphamide by Product in 2024
 Table 41. Novartis Sales Proportion of Cyclophosphamide by Application in 2024
 Table 42. Novartis Sales Proportion of Cyclophosphamide by Geographic Area in 2024
 Table 43. Novartis Recent Developments
 Table 44. Hikma Pharmaceuticals Company Information
 Table 45. Hikma Pharmaceuticals Description and Business Overview
 Table 46. Hikma Pharmaceuticals Cyclophosphamide Product
 Table 47. Hikma Pharmaceuticals Cyclophosphamide Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 48. Hikma Pharmaceuticals Sales Proportion of Cyclophosphamide by Product in 2024
 Table 49. Hikma Pharmaceuticals Sales Proportion of Cyclophosphamide by Application in 2024
 Table 50. Hikma Pharmaceuticals Sales Proportion of Cyclophosphamide by Geographic Area in 2024
 Table 51. Hikma Pharmaceuticals Recent Developments
 Table 52. Amneal Pharmaceuticals LLC Company Information
 Table 53. Amneal Pharmaceuticals LLC Description and Business Overview
 Table 54. Amneal Pharmaceuticals LLC Cyclophosphamide Product
 Table 55. Amneal Pharmaceuticals LLC Cyclophosphamide Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 56. Amneal Pharmaceuticals LLC Sales Proportion of Cyclophosphamide by Product in 2024
 Table 57. Amneal Pharmaceuticals LLC Sales Proportion of Cyclophosphamide by Application in 2024
 Table 58. Amneal Pharmaceuticals LLC Sales Proportion of Cyclophosphamide by Geographic Area in 2024
 Table 59. Amneal Pharmaceuticals LLC Recent Developments
 Table 60. Jiangsu Hengrui Medicine Company Information
 Table 61. Jiangsu Hengrui Medicine Description and Business Overview
 Table 62. Jiangsu Hengrui Medicine Cyclophosphamide Product
 Table 63. Jiangsu Hengrui Medicine Cyclophosphamide Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 64. Jiangsu Hengrui Medicine Sales Proportion of Cyclophosphamide by Product in 2024
 Table 65. Jiangsu Hengrui Medicine Sales Proportion of Cyclophosphamide by Application in 2024
 Table 66. Jiangsu Hengrui Medicine Sales Proportion of Cyclophosphamide by Geographic Area in 2024
 Table 67. Jiangsu Hengrui Medicine Recent Developments
 Table 68. NorthStar Rx LLC Company Information
 Table 69. NorthStar Rx LLC Description and Business Overview
 Table 70. NorthStar Rx LLC Cyclophosphamide Product
 Table 71. NorthStar Rx LLC Cyclophosphamide Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 72. NorthStar Rx LLC Sales Proportion of Cyclophosphamide by Product in 2024
 Table 73. NorthStar Rx LLC Sales Proportion of Cyclophosphamide by Application in 2024
 Table 74. NorthStar Rx LLC Sales Proportion of Cyclophosphamide by Geographic Area in 2024
 Table 75. NorthStar Rx LLC Recent Developments
 Table 76. GLS Pharma Company Information
 Table 77. GLS Pharma Description and Business Overview
 Table 78. GLS Pharma Cyclophosphamide Product
 Table 79. GLS Pharma Cyclophosphamide Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 80. GLS Pharma Sales Proportion of Cyclophosphamide by Product in 2024
 Table 81. GLS Pharma Sales Proportion of Cyclophosphamide by Application in 2024
 Table 82. GLS Pharma Sales Proportion of Cyclophosphamide by Geographic Area in 2024
 Table 83. GLS Pharma Recent Developments
 Table 84. CSC Pharmaceuticals International Company Information
 Table 85. CSC Pharmaceuticals International Description and Business Overview
 Table 86. CSC Pharmaceuticals International Cyclophosphamide Product
 Table 87. CSC Pharmaceuticals International Cyclophosphamide Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. CSC Pharmaceuticals International Sales Proportion of Cyclophosphamide by Product in 2024
 Table 89. CSC Pharmaceuticals International Sales Proportion of Cyclophosphamide by Application in 2024
 Table 90. CSC Pharmaceuticals International Sales Proportion of Cyclophosphamide by Geographic Area in 2024
 Table 91. CSC Pharmaceuticals International Recent Developments
 Table 92. North America Cyclophosphamide Sales by Country (2020-2025) & (Units)
 Table 93. North America Cyclophosphamide Sales by Country (2026-2031) & (Units)
 Table 94. North America Cyclophosphamide Revenue by Country (2020-2025) & (US$ Million)
 Table 95. North America Cyclophosphamide Revenue by Country (2026-2031) & (US$ Million)
 Table 96. North America Cyclophosphamide Sales by Type (2020-2025) & (Units)
 Table 97. North America Cyclophosphamide Sales by Application (2020-2025) & (Units)
 Table 98. Asia-Pacific Cyclophosphamide Sales by Region (2020-2025) & (Units)
 Table 99. Asia-Pacific Cyclophosphamide Sales by Region (2026-2031) & (Units)
 Table 100. Asia-Pacific Cyclophosphamide Revenue by Region (2020-2025) & (US$ Million)
 Table 101. Asia-Pacific Cyclophosphamide Revenue by Region (2026-2031) & (US$ Million)
 Table 102. Asia-Pacific Cyclophosphamide Sales by Type (2020-2025) & (Units)
 Table 103. Asia-Pacific Cyclophosphamide Sales by Application (2020-2025) & (Units)
 Table 104. Europe Cyclophosphamide Sales by Country (2020-2025) & (Units)
 Table 105. Europe Cyclophosphamide Sales by Country (2026-2031) & (Units)
 Table 106. Europe Cyclophosphamide Revenue by Country (2020-2025) & (US$ Million)
 Table 107. Europe Cyclophosphamide Revenue by Country (2026-2031) & (US$ Million)
 Table 108. Europe Cyclophosphamide Sales by Type (2020-2025) & (Units)
 Table 109. Europe Cyclophosphamide Sales by Application (2020-2025) & (Units)
 Table 110. Latin America Cyclophosphamide Sales by Country (2020-2025) & (Units)
 Table 111. Latin America Cyclophosphamide Sales by Country (2026-2031) & (Units)
 Table 112. Latin America Cyclophosphamide Revenue by Country (2020-2025) & (US$ Million)
 Table 113. Latin America Cyclophosphamide Revenue by Country (2026-2031) & (US$ Million)
 Table 114. Latin America Cyclophosphamide Sales by Type (2020-2025) & (Units)
 Table 115. Latin America Cyclophosphamide Sales by Application (2020-2025) & (Units)
 Table 116. Middle East and Africa Cyclophosphamide Sales by Country (2020-2025) & (Units)
 Table 117. Middle East and Africa Cyclophosphamide Sales by Country (2026-2031) & (Units)
 Table 118. Middle East and Africa Cyclophosphamide Revenue by Country (2020-2025) & (US$ Million)
 Table 119. Middle East and Africa Cyclophosphamide Revenue by Country (2026-2031) & (US$ Million)
 Table 120. Middle East and Africa Cyclophosphamide Sales by Type (2020-2025) & (Units)
 Table 121. Middle East and Africa Cyclophosphamide Sales by Application (2020-2025) & (Units)
 Table 122. Cyclophosphamide Key Raw Materials, Industry Status and Trend
 Table 123. Cyclophosphamide Key Raw Materials and Upstream Suppliers
 Table 124. Cyclophosphamide Clients Status and Trend
 Table 125. Cyclophosphamide Typical Clients
 Table 126. Cyclophosphamide Distributors
 Table 127. Cyclophosphamide Market Trends
 Table 128. Cyclophosphamide Market Drivers
 Table 129. Cyclophosphamide Market Challenges
 Table 130. Cyclophosphamide Market Restraints
 Table 131. Research Programs/Design for This Report
 Table 132. Key Data Information from Secondary Sources
 Table 133. Key Data Information from Primary Sources
 Table 134. QYR Business Unit and Senior & Team Lead Analysts


List of Figures
 Figure 1. Cyclophosphamide Product Picture
 Figure 2. Global Cyclophosphamide Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global Cyclophosphamide Sales Market Share by Type in 2024 & 2031
 Figure 4. High-Dose Product Picture
 Figure 5. Low-Dose Product Picture
 Figure 6. Global Cyclophosphamide Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 7. Global Cyclophosphamide Sales Market Share by Application in 2024 & 2031
 Figure 8. Cancer
 Figure 9. Autoimmune Diseases
 Figure 10. AL Amyloidosis
 Figure 11. Others
 Figure 12. Cyclophosphamide Report Years Considered
 Figure 13. Global Cyclophosphamide Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Cyclophosphamide Market Size 2020-2031 (US$ Million)
 Figure 15. Global Cyclophosphamide Sales 2020-2031 (Units)
 Figure 16. Global Cyclophosphamide Sales Market Share Forecast by Region (2020-2031)
 Figure 17. Global Cyclophosphamide Revenue Market Share by Region (2020-2031)
 Figure 18. Global Cyclophosphamide Sales Market Share Forecast by Type (2020-2031)
 Figure 19. Global Cyclophosphamide Revenue Market Share Forecast by Type (2020-2031)
 Figure 20. Cyclophosphamide Average Selling Price (ASP) by Type (2020-2025) & (US$/Unit)
 Figure 21. Global Cyclophosphamide Sales Market Share Forecast by Application (2020-2031)
 Figure 22. Global Cyclophosphamide Revenue Market Share Forecast by Application (2020-2031)
 Figure 23. Cyclophosphamide Average Selling Price (ASP) by Application (2020-2025) & (US$/Unit)
 Figure 24. High-Dose of Cyclophosphamide Revenue Market Share by Application, 2024 VS 2031
 Figure 25. Low-Dose of Cyclophosphamide Revenue Market Share by Application, 2024 VS 2031
 Figure 26. Global Cyclophosphamide Sales Share by Manufacturer in 2024
 Figure 27. Cyclophosphamide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 28. High-Dose Market Sales Proportion by Manufacturer in 2024
 Figure 29. Low-Dose Market Sales Proportion by Manufacturer in 2024
 Figure 30. North America Cyclophosphamide Revenue 2020-2031 (US$ Million)
 Figure 31. North America Cyclophosphamide Sales Market Share by Type (2020-2025)
 Figure 32. North America Cyclophosphamide Sales Market Share by Application (2020-2025)
 Figure 33. Asia-Pacific Cyclophosphamide Revenue 2020-2031 (US$ Million)
 Figure 34. Asia-Pacific Cyclophosphamide Sales Market Share by Region (2020-2031)
 Figure 35. Asia-Pacific Cyclophosphamide Revenue Market Share by Region (2020-2031)
 Figure 36. Asia-Pacific Cyclophosphamide Sales Market Share by Type (2020-2025)
 Figure 37. Asia-Pacific Cyclophosphamide Sales Market Share by Application (2020-2025)
 Figure 38. Europe Cyclophosphamide Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 39. Europe Cyclophosphamide Sales Market Share by Country (2020-2031)
 Figure 40. Europe Cyclophosphamide Revenue Market Share by Country (2020-2031)
 Figure 41. Europe Cyclophosphamide Sales Market Share by Type (2020-2025)
 Figure 42. Europe Cyclophosphamide Sales Market Share by Application (2020-2025)
 Figure 43. Latin America Cyclophosphamide Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 44. Latin America Cyclophosphamide Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Cyclophosphamide Revenue Market Share by Country (2020-2025)
 Figure 46. Latin America Cyclophosphamide Sales Market Share by Type (2020-2025)
 Figure 47. Latin America Cyclophosphamide Sales Market Share by Application (2020-2025)
 Figure 48. Middle East and Africa Cyclophosphamide Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 49. Middle East and Africa Cyclophosphamide Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Cyclophosphamide Revenue Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Cyclophosphamide Sales Market Share by Type (2020-2025)
 Figure 52. Middle East and Africa Cyclophosphamide Sales Market Share by Application (2020-2025)
 Figure 53. Cyclophosphamide Supply Chain (Upstream and Downstream Market)
 Figure 54. Global Production Market Share of Cyclophosphamide Raw Materials by Region in 2024
 Figure 55. Cyclophosphamide Distribution Channels
 Figure 56. Global Cyclophosphamide Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 57. Global Cyclophosphamide Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 58. Bottom-up and Top-down Approaches for This Report
 Figure 59. Data Triangulation
 Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global Cyclophosphamide Injection Market Research Report 2024
Cyclophosphamide Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cisplatin Chemotherapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Platinum based Cancer Drug Market Insights Forecast to 2030
Platinum based Anticancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cyclophosphamide Capsules Market Research Report 2024
Global Cyclophosphamide API Market Research Report 2024
Global Cyclophosphamide for Injection Market Research Report 2024
Global Cisplatin Market Research Report 2024
Global Breast Cancer Treatment Drugs Market Insights Forecast to 2030
Global Neuroblastoma Chemotherapy Drugs Market Research Report 2025
Chemotherapy for Neuroblastoma Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Chemotherapy Drugs for Neuroblastoma Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Vincristine Market Research Report 2024
Platinum Anti tumor Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Chlorambucil Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cyclosporin A Cyclosporin Market Research Report 2024
Global Chemotherapy Drug Market Insights Forecast to 2030
Nelarabine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Chemotherapy Chairs Market Insights Forecast to 2030

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5L19798
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28I6901
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22R9736
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29A2598
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions